clinical trial · NCT06709612
Postsurgical Analgesia After Hernia Repair
AmacaThera Inc.·phase2·withdrawn
Hernia RepairHernia InguinalHernia SurgeryHernia, Inguinal/SurgeryHernia, InguinalAMT-143Saline (NaCl 0,9 %) (placebo)ropivacaine
brief summary
The study is designed to evaluate the safety, efficacy, and pharmacokinetics (PK) of three ascending doses of AMT-143 to determine the appropriate dose of AMT-143 for the management of postsurgical pain following inguinal hernia repair.
started
Jan 27, 2025
primary completion
Mar 1, 2026
completion
May 1, 2026
last updated
Dec 19, 2025
official title
Pilot Phase II Study of AMT-143 for Postsurgical Analgesia After Hernia Repair
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol